News & Articles

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Watch this on-demand webinar to learn about the mechanisms behind cancer treatments such as CAR-T cells, checkpoint inhibitors or adoptive T cell therapy

Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies

Introducing Curiosis’ automated live-cell imaging systems: The Celloger Series

Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains

Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development

Discover the automated, quantitative, and label-free software-hardware integration set to accelerate therapeutics research

Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions

Explore topics from immunoassays and immunotherapeutics to high-sensitivity troponin assays, metabolomics, and in situ hybridization

UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows

Once considered a vestigial organelle, primary cilia are now believed to have an important function in the central nervous system

This agreement brings Bio-Techne's TcBuster system one step closer to delivering gene-modified cell therapies

CryoLogyx will use research emerging from Professor Gibson’s laboratories to transform how cells, and cell-based therapies are stored and transported

The company’s entire cell culture media and reagents portfolios are covered by the new certification